Family · Pharmaceutical analytical standards
Delafloxacin
An antibiotic of the fluoroquinolone family, approved in the United States in 2017 for acute bacterial skin and skin structure infections and later also for community-acquired pneumonia; in Europe since 2019. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Unlike most fluoroquinolones it is anionic: in acidic environments, such as many infection sites, it accumulates up to ten times more in bacteria and cells.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
